BioNTech Investor Day Presentation Deck slide image

BioNTech Investor Day Presentation Deck

Omicron BA.4/5 Monovalent and Bivalent Boosters in Mice Substantially Increase Omicron Neutralization Responses to all Omicron Variants Including BA.4/5 and Reference Strain PVN 50 titer (Serum Dilution-¹) 105 104 103 10² 101 TTTT - Compared to Monovalent OMI BA.1, BA.4/5 neutralizing titers increase by 11.3 fold [mono BA.4/5] or ~4.8 fold (bivalent BA.4/5) 4150 Wuhan 018 3490 1131 617 436 BA.1 BA.2 BA. BA.4/5 2.12.1 9870 4150 5869 4935 4935 Wuhan BA.1 BA.2 BA. BA.4/5 2.12.1 OMI BA.1 OMI BA.4/5 N=8 mice Balb/c mice. Mice preim munized with 2 doses of BNT162b2; boosters given at day 104 Pseudovirus neutralization assay; LOD, Limit of Detection 4H W LOD 5869 2075 2691 3200 2075 GMT Wuhan BA.1 BA.2 BA. BA.4/5 2.12.1 BNT162b2 + OMI BA.4/5 BU-875
View entire presentation